Heart Failure

St. Jude Medical and Thoratec announced that the boards of directors of both companies have unanimously approved a definitive agreement under which St. Jude Medical will acquire all of the outstanding shares of Thoratec. The agreement sets the pri...

While the human heart can’t heal itself, the zebrafish heart can easily replace cells lost by damage or disease. Now, researchers have discovered properties of a mysterious outer layer of the heart known as the epicardium that could help explain t...

Gene therapy can clip out genetic material linked to heart failure and replace it with normal genes, according to a study from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai. The study is published in the April 29 ed...

wearables, ACC.15, ACC 2015, cardiac technology, new technology, cardiology

Several futuristic technologies and their potential impact on healthcare were discussed during the Future of Cardiovascular Medicine track sessions at the American College of Cardiology (ACC) 2015 annual meeting. Among these were use of big data,...

Galectin-3, Architect Galectin-3 assay, BG Medicine, Abbott, heart failure, HF
BG Medicine Inc., developer of the BGM Galectin-3 Test, announced that the Architect Galectin-3 assay is now available. This automated blood test was cleared...
heart failure, Adaptive CRT trial, AdaptivCRT algorithm, readmissions
Heart failure patients had a significantly lower chance of being readmitted within 30 days of discharge when treated with a cardiac resynchronization therapy...
HeartMate PHP, percutaneous heart pump, St. Jude Medical, Thoratec
St. Jude Medical and Thoratec announced that the boards of directors of both companies have unanimously approved a definitive agreement under which St. Jude...
NeoStem, PreSERVE study, AMI, ACC.15, NBS10, CD34 stem cells
NeoStem Inc. presented updated efficacy and safety results from the one-year follow-up for its Phase 2 PreSERVE study and additional analyses of certain...
Galectin-3, Architect Galectin-3 assay, BG Medicine, Abbott, heart failure, HF
The Architect Galectin-3 assay automated blood test from BG Medicine Inc. was cleared by the United States Food and Drug Administration (
Biotronik announced that a unique physiologic sensor is now available in the latest family of cardiac resynchronization therapy...
Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved its DX line of implantable cardioverter defibrillators (...

Articles

HeartMate PHP, percutaneous heart pump, St. Jude Medical, Thoratec
St. Jude Medical and Thoratec announced that the boards of directors of both companies have unanimously approved a definitive agreement under which St. Jude...
NeoStem, PreSERVE study, AMI, ACC.15, NBS10, CD34 stem cells
NeoStem Inc. presented updated efficacy and safety results from the one-year follow-up for its Phase 2 PreSERVE study and additional analyses of certain...
fibrin, MSCs, stem cells, heart failure, Antoni Bayes-Genis, umbilical cord
To date, the only definitive treatment for heart failure – an organ transplant – is hampered by both the limited number of organ donors and the potential for...
cardiomems, st. jude medical, heart failure
Important new data presented during the Heart Rhythm Society's (HRS) 36th annual Scientific Session supporting improved outcomes and cost-effectiveness of the...

Video Center

Here are a few observations on cardiovascular ultrasound advances I made while attending the 2015...
4 weeks 2 days ago
The latest advances in cardiovascular echocardiography will be presented at the 2015 American...
6 weeks 5 days ago
There were several technology takeaway messages for the future of electrophysiology (EP) at the...
9 weeks 5 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...

Comparison Charts

Sorry there is no data available